If approved, Purdue Pharma will contribute $900 million upfront while the Sackler family pays $6.5 billion over the next 15 years – a $500 million increase from the previous settlement.

Potentially $57 million, according to a proposed settlement agreement with the family that once owned Purdue Pharma and has been sued by several states to account for its role in the opioid crisis.

The Sackler family owned and operated Purdue Pharma, LLP, which manufactured OxyContin and advertised the drug as being less addictive. The drug’s effects and use has been far-reaching because ...

Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to email a link to a friend (Opens in new window) Click to share on LinkedIn (Opens in new window ...

The family-owned Purdue Pharma became a household name in the US as the maker and promoter of the prescription painkiller OxyContin, which was promoted as safe, despite being aware it was highly ...

Despite a recently-agreed $7.4 billion settlement, the Sackler family has yet to fully account for its role in America's ...

The Sackler family and Purdue Pharma reached a $7.4 billion settlement with attorneys general from 15 states on Thursday, Jan. 23. The Sacklers have owned the company headquartered in Stamford ...

Purdue Pharma and the Sackler family who controlled it have agreed to pay up to $7.4bn (£6bn) to settle claims regarding its powerful prescription painkiller OxyContin. The deal represents an ...

The Sackler family who owned Purdue Pharma still have tens of billions of dollars in assets, and the U.S. government earned tax revenue from the associated increase in GDP. Re “Canadian health ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

A judge in the US has approved the sale of Purdue Pharma’s consumer health business ... s assets will be transferred to a new company, not owned by the Sacklers, that will devote its profits ...